1.0Fortune Insighthttps://prime.fortuneinsight.com/web鄧建初https://prime.fortuneinsight.com/web/posts/author/chorgorrich600338<blockquote class="wp-embedded-content"><a href="https://prime.fortuneinsight.com/web/posts/495405">雖然估中跌後回升，但是升幅之巨始料不及</a></blockquote> <script type='text/javascript'> <!--//--><![CDATA[//><!-- !function(c,d){"use strict";var e=!1,n=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=d.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o<n.length;o++)n[o].style.display="none";for(o=0;o<s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3<(i=parseInt(t.value,10)))i=1e3;else if(~~i<200)i=200;r.height=i}if("link"===t.message)if(a=d.createElement("a"),i=d.createElement("a"),a.href=r.getAttribute("src"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),d.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(!n){n=!0;for(var e,t,r=-1!==navigator.appVersion.indexOf("MSIE 10"),a=!!navigator.userAgent.match(/Trident.*rv:11\./),i=d.querySelectorAll("iframe.wp-embedded-content"),s=0;s<i.length;s++){if(!(e=i[s]).getAttribute("data-secret"))t=Math.random().toString(36).substr(2,10),e.src+="#?secret="+t,e.setAttribute("data-secret",t);if(r||a)(t=e.cloneNode(!0)).removeAttribute("security"),e.parentNode.replaceChild(t,e)}}}}(window,document); //--><!]]> </script><iframe sandbox="allow-scripts" security="restricted" src="https://prime.fortuneinsight.com/web/posts/495405/embed" width="600" height="338" title="“雖然估中跌後回升，但是升幅之巨始料不及” — Fortune Insight" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe>https://prime.fortuneinsight.com/web/wp-content/uploads/2020/07/24F887F1-D1CE-4749-86C6-3F59F1E64C74.jpeg818551以下資科僅供參考，不構成投資建議。 ＊＊＊＊＊＊＊＊＊＊＊＊＊＊＊ ＊＊＊＊＊＊＊＊＊＊＊＊＊＊＊ 雖然估中跌後回升，但是升幅之巨始料不及 ＊＊＊＊＊＊＊＊＊＊＊＊＊＊＊ ＊＊＊＊＊＊＊＊＊＊＊＊＊＊＊ 恆指昨日最低只見29673，未能跌至29500附近睇好，殊為可惜。今早先行低開，30000點成為好淡雙方攻防戰，可於29800附近睇好，跌穿29670轉弱。 股票方面: 阿里健康(241)成功於26.8元睇好，宜將止賺位推上26.95元。 Vesync(2148)仍可於14.26元睇好，跌穿13.7元轉弱。 醫渡科技(2158)及榮昌生物(9995)仍然強勢，只是走勢飄忽。 可留意新股快手(1024)及心通醫療(2160)。 免責聲明：本人及關聯方可能持有上述推介股票。投資涉及風險，價格可升可跌，買賣股票或期指未必一定賺取利潤，甚至可能變成毫無價值，請考慮本身財務狀況再作決定。